354 related articles for article (PubMed ID: 18838638)
1. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
[TBL] [Abstract][Full Text] [Related]
2. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.
Dunlap LJ; Zarkin GA; Bray JW; Mills M; Kivlahan DR; McKay JR; Latham P; Tonigan JS
Med Care; 2010 Apr; 48(4):306-13. PubMed ID: 20355261
[TBL] [Abstract][Full Text] [Related]
4. Measuring economic outcomes of alcohol treatment using the Economic Form 90.
Bray JW; Zarkin GA; Miller WR; Mitra D; Kivlahan DR; Martin DJ; Couper DJ; Cisler RA
J Stud Alcohol Drugs; 2007 Mar; 68(2):248-55. PubMed ID: 17286343
[TBL] [Abstract][Full Text] [Related]
5. The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.
Zarkin GA; Bray JW; Aldridge A; Mills M; Cisler RA; Couper D; McKay JR; O'Malley S
Med Care; 2010 May; 48(5):396-401. PubMed ID: 20393362
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
[TBL] [Abstract][Full Text] [Related]
8. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
[TBL] [Abstract][Full Text] [Related]
9. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
Doggrell SA
Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440
[TBL] [Abstract][Full Text] [Related]
10. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.
Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R;
J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.
Subbaraman MS; Metrik J; Patterson D; Swift R
Addiction; 2017 Apr; 112(4):685-694. PubMed ID: 27865015
[TBL] [Abstract][Full Text] [Related]
12. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.
COMBINE Study Research Group
Alcohol Clin Exp Res; 2003 Jul; 27(7):1123-31. PubMed ID: 12878918
[TBL] [Abstract][Full Text] [Related]
13. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management].
Rychlik R; Paschen B; Kirchhoff D; Daniel D; Pfeil T; Kilburg A
Dtsch Med Wochenschr; 2001 Aug; 126(33):899-904. PubMed ID: 11514924
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients.
Rychlik R; Siedentop H; Pfeil T; Daniel D
Eur Addict Res; 2003 Apr; 9(2):59-64. PubMed ID: 12644731
[TBL] [Abstract][Full Text] [Related]
16. Relationship between medication adherence and treatment outcomes: the COMBINE study.
Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D
Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687
[TBL] [Abstract][Full Text] [Related]
17. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
18. New pharmacotherapies for alcohol dependence: are they being used and what do they cost?
Doran CM; Fawcett JE; Shakeshaft AP; Shanahan MD; Mattick RP
Med J Aust; 2003 Aug; 179(4):218. PubMed ID: 12914502
[No Abstract] [Full Text] [Related]
19. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence.
Navarro HJ; Shakeshaft A; Doran CM; Petrie DJ
Drug Alcohol Depend; 2012 Aug; 124(3):207-15. PubMed ID: 22361211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
